‘Defensive’ pharma scales new peak as Street looks beyond high-growth plays

August 28, 2024

Pharma stocks have gained investor interest as the Nifty Pharma index reaches new highs. Amid economic uncertainties, defensive sectors like pharma offer minimal risk. Notable picks include Lupin, Sun Pharma, and Dr Reddy’s. The sector saw significant foreign inflows, driven by the performance of the generic drug Revlimid.

More To Explore

Tata Tech hopes to achieve 20-21% margin in next 2-3 years: Warren Harris

Warren Harris, CEO of Tata Tech, discusses the company’s focus on margin preservation and growth in the EV sector. Tata Tech aims to achieve a

September 9, 2024

What to do with Vodafone Idea, HUDCO, Oil India and 3 other stocks? Aamar Deo of Angel One decodes

It is a foregone conclusion that there is a very high probability of a rate cut, it’s the quantum of the cut that is driving

September 9, 2024

Advertiser Disclosure

Great-investor.com helps users across the globe to find out The latest news, Guides, and Info about finance and investments. Furthermore, our content and research teams do not participate in any advertising planning nor are they permitted access to advertising campaign data.

Disclaimer

It is our organization’s primary mission to provide reviews, commentary, and analysis that are unbiased and objective. While great-investor.com has some data verified by industry participants, it can vary from time to time. Operating as an online business, this site may be compensated through third party advertisers. Our receipt of such compensation shall not be construed as an endorsement or recommendation by great-investor.com, nor shall it bias our reviews, analysis, and opinions. Please see our General Disclaimers for more information.

Top10 International FZ LLE | 17th Floor, Creative Tower | 4422 | Fujairah | TRN: 100608946800003